27771196|t|Fluid-Attenuated Inversion Recovery Hyperintensity Is Associated with Hemorrhagic Transformation following Reperfusion Therapy
27771196|a|It is still controversial whether early fluid-attenuated inversion recovery (FLAIR) hyperintensity within acute ischemic lesions carries the risk of hemorrhagic transformation (HT) after reperfusion therapy. Furthermore, the association between the location of FLAIR hyperintensity and HT has not been investigated. We retrospectively reviewed patients who underwent reperfusion therapy within 6 hours of stroke onset and magnetic resonance imaging including a FLAIR sequence before completing reperfusion therapy. FLAIR hyperintensity within the diffusion-weighted imaging (DWI) lesion was rated qualitatively, and HT was assessed on follow-up gradient echo imaging. The location of the FLAIR change and HT was classified as subcortical, cortical, or cortico-subcortical. Of 134 patients with acute ischemic stroke included in this study, early FLAIR changes within DWI lesions were identified in 56 (41.8%) patients, and HT was noted in 51 (38.1%) patients. FLAIR change was independently associated with HT (odds ratio: 4.37, 95% confidence interval: 1.72-11.12). Geographically, 48.2% of the patients with a FLAIR change developed a matched HT (restricted to the region with the FLAIR change), and the risk of HT was further increased in patients with a FLAIR change in the cortico-subcortical region (68.8%). In patients in the acute stage of stroke, an early FLAIR change is associated with the risk of HT following reperfusion therapy with a highly matched geographic relationship and common risk factors. Thus, identification of FLAIR change may be a useful surrogate marker to assess the likelihood of subsequent HT in patients treated with reperfusion therapy.
27771196	0	35	Fluid-Attenuated Inversion Recovery	T060	C2826145
27771196	36	50	Hyperintensity	T046	C2938912
27771196	54	69	Associated with	T080	C0332281
27771196	70	96	Hemorrhagic Transformation	T047	C1096400
27771196	107	126	Reperfusion Therapy	T061	C0035124
27771196	167	202	fluid-attenuated inversion recovery	T060	C2826145
27771196	204	209	FLAIR	T060	C2826145
27771196	211	225	hyperintensity	T046	C2938912
27771196	233	238	acute	T079	C0205178
27771196	239	247	ischemic	T046	C0022116
27771196	248	255	lesions	T033	C0221198
27771196	268	272	risk	T078	C0035647
27771196	276	302	hemorrhagic transformation	T047	C1096400
27771196	304	306	HT	T047	C1096400
27771196	314	333	reperfusion therapy	T061	C0035124
27771196	376	384	location	T029	C1515974
27771196	388	393	FLAIR	T060	C2826145
27771196	394	408	hyperintensity	T046	C2938912
27771196	413	415	HT	T047	C1096400
27771196	429	441	investigated	T169	C1292732
27771196	446	461	retrospectively	T080	C1514923
27771196	462	470	reviewed	T080	C1709940
27771196	471	479	patients	T101	C0030705
27771196	494	513	reperfusion therapy	T061	C0035124
27771196	532	538	stroke	T047	C1096400
27771196	539	544	onset	T080	C0332162
27771196	549	575	magnetic resonance imaging	T060	C0024485
27771196	588	593	FLAIR	T060	C2826145
27771196	594	602	sequence	T169	C1519249
27771196	621	640	reperfusion therapy	T061	C0035124
27771196	642	647	FLAIR	T060	C2826145
27771196	648	662	hyperintensity	T046	C2938912
27771196	674	700	diffusion-weighted imaging	T060	C0598801
27771196	702	705	DWI	T060	C0598801
27771196	707	713	lesion	T033	C0221198
27771196	718	723	rated	T052	C0871208
27771196	724	737	qualitatively	T080	C0205556
27771196	743	745	HT	T047	C1096400
27771196	750	758	assessed	T052	C1516048
27771196	762	771	follow-up	T079	C0332283
27771196	772	780	gradient	T081	C0812409
27771196	781	793	echo imaging	T060	C0162734
27771196	815	820	FLAIR	T060	C2826145
27771196	821	827	change	T169	C0392747
27771196	832	834	HT	T047	C1096400
27771196	853	864	subcortical	T029	C0815275
27771196	866	874	cortical	T023	C0007776
27771196	879	898	cortico-subcortical	T029	C1515974
27771196	907	915	patients	T101	C0030705
27771196	921	926	acute	T079	C0205178
27771196	927	942	ischemic stroke	T047	C0948008
27771196	973	978	FLAIR	T060	C2826145
27771196	979	986	changes	T169	C0392747
27771196	994	997	DWI	T060	C0598801
27771196	998	1005	lesions	T033	C0221198
27771196	1036	1044	patients	T101	C0030705
27771196	1050	1052	HT	T047	C1096400
27771196	1077	1085	patients	T101	C0030705
27771196	1087	1092	FLAIR	T060	C2826145
27771196	1093	1099	change	T169	C0392747
27771196	1104	1117	independently	T078	C0085862
27771196	1118	1133	associated with	T080	C0332281
27771196	1134	1136	HT	T047	C1096400
27771196	1194	1208	Geographically	UnknownType	C0681784
27771196	1223	1231	patients	T101	C0030705
27771196	1239	1244	FLAIR	T060	C2826145
27771196	1245	1251	change	T169	C0392747
27771196	1272	1274	HT	T047	C1096400
27771196	1310	1315	FLAIR	T060	C2826145
27771196	1316	1322	change	T169	C0392747
27771196	1333	1337	risk	T078	C0035647
27771196	1341	1343	HT	T047	C1096400
27771196	1356	1365	increased	T081	C0205217
27771196	1369	1377	patients	T101	C0030705
27771196	1385	1390	FLAIR	T060	C2826145
27771196	1391	1397	change	T169	C0392747
27771196	1405	1431	cortico-subcortical region	T029	C1515974
27771196	1444	1452	patients	T101	C0030705
27771196	1460	1465	acute	T079	C0205178
27771196	1466	1471	stage	T079	C1306673
27771196	1475	1481	stroke	T047	C1096400
27771196	1492	1497	FLAIR	T060	C2826145
27771196	1498	1504	change	T169	C0392747
27771196	1508	1523	associated with	T080	C0332281
27771196	1528	1532	risk	T078	C0035647
27771196	1536	1538	HT	T047	C1096400
27771196	1549	1568	reperfusion therapy	T061	C0035124
27771196	1626	1638	risk factors	T033	C0035648
27771196	1646	1660	identification	T080	C0205396
27771196	1664	1669	FLAIR	T060	C2826145
27771196	1670	1676	change	T169	C0392747
27771196	1693	1709	surrogate marker	T080	C0086589
27771196	1713	1719	assess	T058	C0184514
27771196	1724	1734	likelihood	T081	C0033204
27771196	1749	1751	HT	T047	C1096400
27771196	1755	1763	patients	T101	C0030705
27771196	1764	1776	treated with	T061	C0332293
27771196	1777	1796	reperfusion therapy	T061	C0035124